Vestor Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.1M | Buy |
680,897
+680,445
| +150,541% | +$18.1M | 1.38% | 20 |
|
|
2025
Q4 | $297K | Sell |
452
-11,483
| -96% | -$290K | 0.02% | 117 |
|
|
2025
Q3 | $304K | Buy |
11,935
+9,124
| +325% | +$225K | 0.02% | 136 |
|
|
2025
Q2 | $113K | Sell |
2,811
-7,915
| -74% | -$185K | 0.01% | 180 |
|
|
2025
Q1 | $272K | Sell |
10,726
-8
| -0.1% | -$209 | 0.02% | 119 |
|
|
2024
Q4 | $285K | Buy |
10,734
+1,710
| +19% | +$46.4K | 0.02% | 135 |
|
|
2024
Q3 | $261K | Sell |
9,024
-304
| -3% | -$8.87K | 0.02% | 110 |
|
|
2024
Q2 | $261K | Sell |
9,328
-4,499
| -33% | -$124K | 0.02% | 110 |
|
|
2024
Q1 | $384K | Sell |
13,827
-296
| -2% | -$8.21K | 0.03% | 110 |
|
|
2023
Q4 | $407K | Sell |
14,123
-1,219
| -8% | -$36.9K | 0.04% | 101 |
|
|
2023
Q3 | $509K | Sell |
15,342
-632
| -4% | -$22.3K | 0.06% | 97 |
|
|
2023
Q2 | $586K | Buy |
15,974
+1,022
| +7% | +$39.8K | 0.06% | 91 |
|
|
2023
Q1 | $610K | Sell |
14,952
-545
| -4% | -$23.5K | 0.07% | 107 |
|
|
2022
Q4 | $794K | Buy |
15,497
+813
| +6% | +$39K | 0.1% | 100 |
|
|
2022
Q3 | $643K | Buy |
14,684
+1
| +0% | +$49 | 0.08% | 92 |
|
|
2022
Q2 | $770K | Hold |
14,683
| – | – | 0.09% | 83 |
|
|
2022
Q1 | $760K | Sell |
14,683
-180
| -1% | -$9.34K | 0.08% | 86 |
|
|
2021
Q4 | $878K | Buy |
14,863
+2,500
| +20% | +$124K | 0.08% | 83 |
|
|
2021
Q3 | $532K | Buy |
12,363
+500
| +4% | +$22.1K | 0.06% | 93 |
|
|
2021
Q2 | $465K | Buy |
11,863
+600
| +5% | +$23.3K | 0.05% | 91 |
|
|
2021
Q1 | $408K | Hold |
11,263
| – | – | 0.05% | 89 |
|
|
2020
Q4 | $415K | Buy |
11,263
+621
| +6% | +$22.8K | 0.05% | 84 |
|
|
2020
Q3 | $371K | Buy |
+10,642
| New | +$373K | 0.05% | 77 |
|
|
2020
Q1 | $327K | Sell |
10,545
-268
| -2% | -$9.13K | 0.06% | 79 |
|
|
2019
Q4 | $402K | Buy |
10,813
+5,368
| +99% | +$191K | 0.06% | 86 |
|
|
2019
Q3 | $186K | Buy |
5,445
+3,814
| +234% | +$139K | 0.03% | 82 |
|
|
2019
Q2 | $67K | Buy |
1,631
+613
| +60% | +$24.3K | 0.01% | 98 |
|
|
2019
Q1 | $41K | Sell |
1,018
-1,209
| -54% | -$48.4K | 0.01% | 142 |
|
|
2018
Q4 | $92K | Buy |
2,227
+967
| +77% | +$40.1K | 0.02% | 84 |
|
|
2018
Q3 | $53K | Buy |
+1,260
| New | +$48.5K | 0.01% | 105 |
|
|
2017
Q4 | – | Sell |
-1,569
| Closed | -$53K | – | 121 |
|
|
2017
Q3 | $53K | Buy |
1,569
+281
| +22% | +$9.03K | 0.01% | 110 |
|
|
2017
Q2 | $41K | Sell |
1,288
-925
| -42% | -$29.2K | 0.01% | 123 |
|
|
2017
Q1 | $72K | Hold |
2,213
| – | – | 0.02% | 121 |
|
|
2016
Q4 | $68K | Sell |
2,213
-95
| -4% | -$2.9K | 0.02% | 81 |
|
|
2016
Q3 | $74K | Hold |
2,308
| – | – | 0.02% | 87 |
|
|
2016
Q2 | $77K | Hold |
2,308
| – | – | 0.02% | 76 |
|
|
2016
Q1 | $65K | Buy |
+2,308
| New | +$65.9K | 0.02% | 80 |
|
|
2015
Q3 | – | Sell |
-2,364
| Closed | -$75K | – | 120 |
|
|
2015
Q2 | $75K | Hold |
2,364
| – | – | 0.02% | 86 |
|
|
2015
Q1 | $78K | Buy |
2,364
+915
| +63% | +$29.1K | 0.03% | 79 |
|
|
2014
Q4 | $43K | Buy |
+1,449
| New | +$41.5K | 0.01% | 109 |
|
Other funds holding PFE
VCM
VPM
Vestor Capital's PFE Position: Q1 2026 in Review
Vestor Capital increased its Pfizer (PFE) stake by 150,541% in Q1 2026, buying an estimated $18.1M and bringing the position to 680,897 shares worth $19.1M. The position accounts for 1.38% of the portfolio, ranked #20.
Vestor Capital first reported a position in PFE in Q4 2014 and has held it in 40 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Vestor Capital held 680,897 shares of Pfizer worth $19.1M as of Q1 2026.
- Vestor Capital bought 680,445 Pfizer shares in Q1 2026, an estimated $18.1M.
- Pfizer made up 1.38% of Vestor Capital's portfolio in Q1 2026, its #20 holding.
- Vestor Capital first reported a position in Pfizer in Q4 2014 and has held it in 40 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.